The Latest Cardiac and Vascular News
WAYNE, Pa., May 02, 2023 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the launch of two new devices designed to enhance PICC insertion procedures and reduce the chance of complications. The new Arrow® VPS Rhythm® DLX Device and NaviCurve™ Stylet are […]
Triumph™ Catheter and GuideLiner® Coast™ Catheter to be featured at the CTO Plus Conference, February 23-24 in New York, NY WAYNE, Pa., Feb. 22, 2023 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced key milestones in the release of two new catheters: the […]
Midline options designed to fit the needs of clinicians and patients WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) releases their new Arrow® Pressure Injectable Midline portfolio in the US and Canada, designed to help alleviate line identification confusion. Clinicians can choose between the Arrowg+ard Blue Advance® Midline […]
WAYNE, Pa., July 28, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable September 15, 2022, to shareholders of record at the close of business on […]
Study Intends to Demonstrate that Ultrasound Allows for Precise Deployment and Positive Positioning of the MANTA® Vascular Closure Device WAYNE, Pa., June 22, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical study that is […]
Designed to help clinicians overcome catheter identification confusion WAYNE, Pa., June 13, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced the launch of an Arrow Pressure Injectable Midline Catheter in Australia and New Zealand. The addition of the pressure injectable […]
WAYNE, Pa., May 18, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the MANTA® Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access […]
WAYNE, Pa., April 28, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the first quarter ended March 27, 2022. First quarter financial summary Revenues of $641.7 million, up 1.2% year-over-year; up 3.2% on a constant currency basis GAAP diluted EPS from continuing operations of $1.63, […]
Results of CTO-PCI IDE Study Demonstrate Procedural Success with Teleflex Specialty Catheters and Coronary Guidewires in Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Interventions WAYNE, Pa., Feb. 23, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the U.S. Food and […]
WAYNE, Pa., Oct. 28, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 26, 2021. Third quarter financial summary Reported revenues of $700.3 million, up 11.5% year-over-year; up 10.3% on a constant currency basis GAAP diluted EPS from continuing operations of […]
